US Patent Issued to Regents of the University of Minnesota, HENNEPIN HEALTHCARE RESEARCH INSTITUTE on April 7 for "Anti-opioid compounds and methods of making and using same" (Minnesota Inventors)

ALEXANDRIA, Va., April 7 -- United States Patent no. 12,594,330, issued on April 7, was assigned to Regents of the University of Minnesota (Minneapolis) and HENNEPIN HEALTHCARE RESEARCH INSTITUTE (Minneapolis).

"Anti-opioid compounds and methods of making and using same" was invented by Marco Pravetoni (Minneapolis) and Carly Baehr (Minneapolis).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure describes opioid-specific monoclonal antibodies (mAb), methods of making those antibodies, and methods of using those antibodies. The methods include, for example, treating a subject with an opioid use disorder or neonatal opioid withdrawal syndrome or preventing and reversing opioid overdose in a subject....